FDA 483 - Dr. Maki , Jeffrey, - December 21, 2010

An FDA inspection of Dr. Jeffrey H. Maki, a clinical investigator in Seattle, WA, revealed significant deficiencies in the retention of investigational records. The firm failed to retain study records for two different drug study protocols, impacting 132 subjects. This included critical source documents such as informed consent forms, case histories, and drug accountability records.